It was 2012, and Doug Chapnick was fed up with traditional biochemistry research.
That kind of thinking first led him to a Department of Defense-funded project, which involved white powders and Rube Goldberg-esque experiments, and then to founding a biotech company called BioLoomics, which is trying to develop new protein…
Click here to view original post
